EGFR and non-small cell lung carcinoma: To develop a model to study a saturated library of mutated EGFR proteins in a physiologically context, we validated the use of PC9 cells, a non-small cell lung cancer (NSCLC) cell line, which contains an endogenous EGFR exon 19 deletion.